These guidelines prescribe data, which is required to be submitted to the National Drug Authority to demonstrate the safety, efficacy and quality of vaccines being applied for market authorization. The guidelines also describe the format (CTD) in which dossiers should be presented in support of the application.
This decision by the minister of public health provides for pricing scheme for the treatment of severe malaria.
This decision by the minister of public health provides the prices and conditions of availability of rapid malaria diagnosis kits.
The law creates a public administrative establishment, with legal personality and financial autonomy, called the Centre national de lutte contre le cancer (National Cancer Center).
Dangerous Drug Act
This Act provides for the regulation, control and classification of dangerous drugs.